Detalles de la búsqueda
1.
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective, real-world experience with 200 cases outside of controlled clinical trials.
Haematologica
; 109(1): 245-255, 2024 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37439329
2.
Myeloma cells regulate miRNA transfer from fibroblast-derived exosomes by expression of lncRNAs.
J Pathol
; 256(4): 402-413, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34919276
3.
Lung Ultrasound Is Useful for Evaluating Lung Damage in COVID-19 Patients Treated with Bamlanivimab and Etesevimab: A Single-Center Pilot Study.
Medicina (Kaunas)
; 59(2)2023 Jan 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-36837405
4.
Thrombopoietin Promotes Angiogenesis and Disease Progression in Patients with Multiple Myeloma.
Am J Pathol
; 191(4): 748-758, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33516787
5.
Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials.
Hematol Oncol
; 40(4): 704-715, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35608183
6.
Adjusted comparison between elotuzumab and carfilzomib in combination with lenalidomide and dexamethasone as salvage therapy for multiple myeloma patients.
Eur J Haematol
; 108(3): 178-189, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34716957
7.
Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores angiogenic homeostasis and suppresses tumor progression.
Haematologica
; 106(7): 1943-1956, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32354870
8.
Treating secondary antibody deficiency in patients with haematological malignancy: European expert consensus.
Eur J Haematol
; 106(4): 439-449, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33453130
9.
Bone Marrow Stromal Cells-Induced Drug Resistance in Multiple Myeloma.
Int J Mol Sci
; 21(2)2020 Jan 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-31963513
10.
Functional interplay between NF-κB-inducing kinase and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma.
Haematologica
; 104(12): 2465-2481, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30948493
11.
Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study).
Ann Hematol
; 98(2): 361-367, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30353388
12.
Subcutaneous immunoglobulins in patients with multiple myeloma and secondary hypogammaglobulinemia: a randomized trial.
Clin Immunol
; 191: 110-115, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29191714
13.
Different Adaptive Responses to Hypoxia in Normal and Multiple Myeloma Endothelial Cells.
Cell Physiol Biochem
; 46(1): 203-212, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29587264
14.
Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killing.
Blood
; 126(12): 1443-51, 2015 Sep 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-26185130
15.
Lenalidomide and low-dose dexamethasone (Rd) versus bortezomib, melphalan, prednisone (VMP) in elderly newly diagnosed multiple myeloma patients: A comparison of two prospective trials.
Am J Hematol
; 92(3): 244-250, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28006855
16.
Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials.
Haematologica
; 106(1): 291-294, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32107338
17.
Echocardiographic findings and plasma endothelin-1 levels in obese patients with and without obstructive sleep apnea.
Sleep Breath
; 20(2): 613-9, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26385777
18.
Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial.
Lancet Oncol
; 16(16): 1617-29, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26596670
19.
Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross-talk in the bone marrow of multiple myeloma patients.
J Pathol
; 229(1): 87-98, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22847671
20.
A Novel Automatic Algorithm to Support Lung Ultrasound Non-Expert Physicians in Interstitial Pneumonia Evaluation: A Single-Center Study.
Diagnostics (Basel)
; 14(2)2024 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38248032